title: A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice.
abstract: The transmission of H5N1 influenza viruses from birds to humans poses a significant public health threat. A substitution of glutamic acid for lysine at position 627 of the PB2 protein of H5N1 viruses has been identified as a virulence determinant. We utilized the BALB/c mouse model of H5N1 infection to examine how this substitution affects virus-host interactions and leads to systemic infection. Mice infected with H5N1 viruses containing lysine at amino acid 627 in the PB2 protein exhibited an increased severity of lesions in the lung parenchyma and the spleen, increased apoptosis in the lungs, and a decrease in oxygen saturation. Gene expression profiling revealed that T-cell receptor activation was impaired at 2 days postinfection (dpi) in the lungs of mice infected with these viruses. The inflammatory response was highly activated in the lungs of mice infected with these viruses and was sustained at 4 dpi. In the spleen, immune-related processes including NK cell cytotoxicity and antigen presentation were highly activated by 2 dpi. These differences are not attributable solely to differences in viral replication in the lungs but to an inefficient immune response early in infection as well. The timing and magnitude of the immune response to highly pathogenic influenza viruses is critical in determining the outcome of infection. The disruption of these factors by a single-amino-acid substitution in a polymerase protein of an influenza virus is associated with severe disease and correlates with the spread of the virus to extrapulmonary sites.
authors.affiliation: Department of Microbiology, University of Washington, Box 358070, Seattle, WA 98195, USA.
authors.forename: Jamie L
authors.initials: JL
authors.lastname: Fornek
authors.forename: Laura
authors.initials: L
authors.lastname: Gillim-Ross
authors.forename: Celia
authors.initials: C
authors.lastname: Santos
authors.forename: Victoria
authors.initials: V
authors.lastname: Carter
authors.forename: Jerrold M
authors.initials: JM
authors.lastname: Ward
authors.forename: Lily I
authors.initials: LI
authors.lastname: Cheng
authors.forename: Sean
authors.initials: S
authors.lastname: Proll
authors.forename: Michael G
authors.initials: MG
authors.lastname: Katze
authors.forename: Kanta
authors.initials: K
authors.lastname: Subbarao
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D005260:Female; D020869:Gene Expression Profiling; D016679:Genome, Viral; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000201:enzymology / Q000235:genetics / Q000472:pathogenicity; D007251:Influenza, Human / Q000276:immunology / Q000821:virology; D008168:Lung / Q000166:cytology / Q000378:metabolism / Q000473:pathology / Q000821:virology; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D046228:Microarray Analysis; D008969:Molecular Sequence Data; D009976:Orthomyxoviridae Infections / Q000276:immunology* / Q000821:virology*; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism; D015398:Signal Transduction; D013154:Spleen / Q000166:cytology / Q000378:metabolism / Q000473:pathology / Q000821:virology; D013601:T-Lymphocytes / Q000276:immunology*; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D014779:Virus Replication
chemical_list: C502893:PB2 protein, influenza virus; D011948:Receptors, Antigen, T-Cell; D014764:Viral Proteins
references.citation: Lancet. 1998 Feb 14;351(9101):467-71
references.pmid: 9482437
references.citation: J Virol. 2008 Aug;82(16):8030-7
references.pmid: 18524833
references.citation: PLoS Pathog. 2007 Oct 5;3(10):1414-21
references.pmid: 17922571
references.citation: Science. 2007 Jan 26;315(5811):528-31
references.pmid: 17185562
references.citation: Antimicrob Agents Chemother. 1992 Feb;36(2):473-6
references.pmid: 1605614
references.citation: Nature. 1997 Oct 9;389(6651):554
references.pmid: 9335492
references.citation: J Exp Med. 2006 Mar 20;203(3):689-97
references.pmid: 16533883
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18590-5
references.pmid: 16339318
references.citation: Science. 2001 Sep 7;293(5536):1840-2
references.pmid: 11546875
references.citation: J Virol. 1999 Apr;73(4):3184-9
references.pmid: 10074171
references.citation: Virus Res. 2007 Sep;128(1-2):159-63
references.pmid: 17521765
references.citation: J Virol. 2000 Feb;74(3):1443-50
references.pmid: 10627555
references.citation: Cell Host Microbe. 2008 Aug 14;4(2):111-22
references.pmid: 18692771
references.citation: J Virol. 2008 Feb;82(4):2028-32
references.pmid: 18077718
references.citation: Nat Immunol. 2006 May;7(5):517-23
references.pmid: 16565719
references.citation: Nat Immunol. 2000 Jul;1(1):23-9
references.pmid: 10881170
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3064-9
references.pmid: 18287069
references.citation: J Virol. 2000 Jul;74(13):6105-16
references.pmid: 10846094
references.citation: Immunity. 2007 Aug;27(2):190-202
references.pmid: 17723214
references.citation: J Virol. 2007 Oct;81(19):10558-66
references.pmid: 17634234
references.citation: Science. 1998 Jan 16;279(5349):393-6
references.pmid: 9430591
references.citation: J Virol. 1993 Apr;67(4):1761-4
references.pmid: 8445709
references.citation: Nat Genet. 2001 Dec;29(4):365-71
references.pmid: 11726920
references.citation: J Virol. 2000 Nov;74(22):10807-10
references.pmid: 11044127
references.citation: J Virol. 2007 Aug;81(16):8515-24
references.pmid: 17553873
references.citation: J Virol. 1999 Jul;73(7):5903-11
references.pmid: 10364342
references.citation: J Immunol. 2007 Mar 1;178(5):2688-98
references.pmid: 17312110
references.citation: Nature. 2006 Oct 5;443(7111):578-81
references.pmid: 17006449
references.citation: Virology. 2004 Mar 15;320(2):258-66
references.pmid: 15016548